Steve Brozak

Stock Analyst at WBB Securities

(0.27)
# 4,122
Out of 4,854 analysts
7
Total ratings
22.22%
Success rate
-19.17%
Average return

Stocks Rated by Steve Brozak

Marker Therapeutics
Apr 1, 2025
Reiterates: Strong Buy
Price Target: $13
Current: $1.49
Upside: +738.93%
Cidara Therapeutics
Sep 22, 2021
Upgrades: Strong Buy
Price Target: n/a
Current: $24.00
Upside: -
Omeros
Jun 18, 2021
Maintains: Strong Buy
Price Target: $75$100
Current: $3.30
Upside: +2,930.30%
RedHill Biopharma
May 28, 2021
Downgrades: Buy
Price Target: $17,000$16,000
Current: $1.93
Upside: +828,915.54%